FDA’s Robyn Bent On The Evolution of Patient-Focused Drug Development
Executive Summary
The director of the agency’s patient-focused drug development program talks about how the program has improved the development and evaluation of new drugs, initiatives underway, and plans to standardize and harmonize the process.